关注
Xiangang Huang (黄咸钢)
Xiangang Huang (黄咸钢)
Postdoctoral Researcher at Harvard Medical School; PhD at ETH Zurich
在 childrens.harvard.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Polydopamine-coated nucleic acid nanogel for siRNA-mediated low-temperature photothermal therapy
F Ding, X Gao, X Huang, H Ge, M Xie, J Qian, J Song, Y Li, X Zhu, ...
Biomaterials 245, 119976, 2020
2082020
The landscape of mRNA nanomedicine
X Huang, N Kong, X Zhang, Y Cao, R Langer, W Tao
Nature Medicine 28 (11), 2273-2287, 2022
2072022
Arsenene Nanodots with Selective Killing Effects and their Low‐Dose Combination with ß‐Elemene for Cancer Therapy
C Liu, S Sun, Q Feng, G Wu, Y Wu, N Kong, Z Yu, J Yao, X Zhang, ...
Advanced Materials 33 (37), 2102054, 2021
1222021
mRNA-based cancer therapeutics
C Liu, Q Shi, X Huang, S Koo, N Kong, W Tao
Nature Reviews Cancer 23 (8), 526-543, 2023
1132023
Well-defined multivalent ligands for hepatocytes targeting via asialoglycoprotein receptor
X Huang, JC Leroux, B Castagner
Bioconjugate chemistry 28 (2), 283-295, 2017
1112017
Emerging mRNA technologies: delivery strategies and biomedical applications
Y Xiao#, Z Tang#, X Huang#, W Chen, J Zhou, H Liu, C Liu, N Kong, ...
Chemical Society Reviews, 2022
1082022
Blood-brain barrier–penetrating single CRISPR-Cas9 nanocapsules for effective and safe glioblastoma gene therapy
Y Zou, X Sun, Q Yang, M Zheng, O Shimoni, W Ruan, Y Wang, D Zhang, ...
Science advances 8 (16), eabm8011, 2022
1022022
Nanotechnology-based strategies against SARS-CoV-2 variants
X Huang, E Kon, X Han, X Zhang, N Kong, MJ Mitchell, D Peer, W Tao
Nature Nanotechnology 17 (10), 1027-1037, 2022
792022
A non-cationic nucleic acid nanogel for the delivery of the CRISPR/Cas9 gene editing tool
F Ding, X Huang, X Gao, M Xie, G Pan, Q Li, J Song, X Zhu, C Zhang
Nanoscale 11 (37), 17211-17215, 2019
752019
Triple-stimuli (pH/thermo/reduction) sensitive copolymers for intracellular drug delivery
X Huang, X Jiang, Q Yang, Y Chu, G Zhang, B Yang, R Zhuo
Journal of Materials Chemistry B 1 (13), 1860-1868, 2013
662013
Synthesis of siRNA nanoparticles to silence plaque-destabilizing gene in atherosclerotic lesional macrophages
X Huang, C Liu, N Kong, Y Xiao, A Yurdagul Jr, I Tabas, W Tao
Nature protocols 17 (3), 748-780, 2022
592022
Nanoscale materials-based platforms for the treatment of bone-related diseases
X Zhang#, S Koo#, JH Kim#, X Huang#, N Kong, L Zhang, J Zhou, J Xue, ...
Matter 4 (9), 2727-2764, 2021
572021
Characterization of calcium phosphate nanoparticles based on a PEGylated chelator for gene delivery
X Huang, D Andina, J Ge, A Labarre, JC Leroux, B Castagner
ACS applied materials & interfaces 9 (12), 10435-10445, 2017
472017
pH-responsive and gemcitabine-containing DNA nanogel to facilitate the chemodrug delivery
G Pan, Q Mou, Y Ma, F Ding, J Zhang, Y Guo, X Huang, Q Li, X Zhu, ...
ACS applied materials & interfaces 11 (44), 41082-41090, 2019
462019
Nano-bio interfaces effect of two-dimensional nanomaterials and their applications in cancer immunotherapy
Z Tang, Y Xiao, N Kong, C Liu, W Chen, X Huang, D Xu, J Ouyang, ...
Acta Pharmaceutica Sinica B 11 (11), 3447-3464, 2021
412021
Oral drug delivery platforms for biomedical applications
J Ouyang, Z Zhang, B Deng, J Liu, L Wang, H Liu, S Koo, S Chen, Y Li, ...
Materials Today 62, 296-326, 2023
392023
RNA cancer nanomedicine: nanotechnology-mediated RNA therapy
BE Ferdows, DN Patel, W Chen, X Huang, N Kong, W Tao
Nanoscale 14 (12), 4448-4455, 2022
392022
Glucose-responsive oral insulin delivery platform for one treatment a day in diabetes
Y Xiao, Z Tang, X Huang, J Joseph, W Chen, C Liu, J Zhou, N Kong, ...
Matter 4 (10), 3269-3285, 2021
392021
Intercalation-driven formation of siRNA nanogels for cancer therapy
X Huang, G Wu, C Liu, X Hua, Z Tang, Y Xiao, W Chen, J Zhou, N Kong, ...
Nano Letters 21 (22), 9706-9714, 2021
372021
Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy
X Huang, NT Blum, J Lin, J Shi, C Zhang, P Huang
Materials horizons 8 (1), 78-101, 2021
362021
系统目前无法执行此操作,请稍后再试。
文章 1–20